Get the Stockscreener App
4.70
4.08%
-0.20
After Hours:
4.70
Ispecimen Inc stock is traded at $4.70, with a volume of 120.83K.
It is down -4.08% in the last 24 hours and down -12.96% over the past month.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.
See More
Previous Close:
$4.90
Open:
$4.76
24h Volume:
120.83K
Relative Volume:
0.82
Market Cap:
$3.08M
Revenue:
$9.93M
Net Income/Loss:
$-11.10M
P/E Ratio:
-3.76
EPS:
-1.25
Net Cash Flow:
$-10.55M
1W Performance:
-15.47%
1M Performance:
-12.96%
6M Performance:
+1.29%
1Y Performance:
-62.10%
1-Day Range:
$4.64
$5.07
1-Week Range:
$4.50
$5.94
52-Week Range:
$3.4101
$14.60
Ispecimen Inc Stock (ISPC) Company Profile
Name
Ispecimen Inc
Sector
Industry
Phone
781-301-6700
Address
450 BEDFORD STREET, LEXINGTON
Ispecimen Inc Stock (ISPC) Latest News
Trend Tracker for (ISPC) - Stock Traders Daily
iSpecimen secures $1M loan, appoints three board members - TipRanks
iSpecimen secures $1 million loan, revamps board - Investing.com
iSpecimen Secures $1 Million Loan; Appoints Three New Board Members - citybiz
ISpecimen Inc. Announces Board Changes - Marketscreener.com
iSpecimen Secures $1 Million Loan; Appoints Three New Board Members - The Manila Times
iSpecimen Secures $1 Million Loan; Appoints Three New Board Members - StockTitan
iSpecimen Bolsters Finance with Loan and Board Revamp - TipRanks
ISPC Stock: Exploring iSpecimen Inc’s Growth - The InvestChronicle
iSpecimen Inc. (NASDAQ:ISPC) Short Interest Down 8.3% in August - MarketBeat
Investing in iSpecimen Inc (ISPC) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News
Ratio Revelations: iSpecimen Inc (ISPC)’s Financial Metrics in the Spotlight - The Dwinnex
ISPC Stock: A Comprehensive Analysis and Forecast - The InvestChronicle
Upcoming Stock Splits This Week (September 16 to September 20) – Stay Invested - MSN
United States shares mixed at close of trade; Dow Jones Industrial Average up 0.55% - MSN
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.55% - MSN
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.55% - Investing.com
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.55% - Investing.com UK
Upcoming Stock Splits This Week (September 16 to September 20) – Stay InvestingTHE BHARAT EXPRESS NEWS - The Bharat Express News
Upcoming Stock Splits This Week (September 16 to September 20) – Stay Invested - EMEA Tribune, Breaking News, World News, Latest News, Top Headlines
iSpecimen Inc (ISPC) can make a big difference with a little luck - SETE News
Upcoming Stock Splits This Week (September 16 to September 20) – Stay Invested - TipRanks
iSpecimen Inc (ISPC)’s stock decline to 0.19 per share - US Post News
iSpecimen Inc. (NASDAQ:ISPC) Might Not Be As Mispriced As It Looks After Plunging 32% - Simply Wall St
iSpecimen stock hits 52-week low at $0.20 amid market challenges - Investing.com
iSpecimen stock hits 52-week low at $0.20 amid market challenges - Investing.com UK
iSpecimen announces 1-for-20 reverse stock split By Investing.com - Investing.com Australia
Ratios in Focus: Analyzing iSpecimen Inc (ISPC)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket - Benzinga
iSpecimen announces 1-for-20 reverse stock split - MSN
iSpecimen Announces 1-for-20 Reverse Stock Split - citybiz
iSpecimen Announces 1-for-20 Reverse Stock Split - ForexTV.com
iSpecimen announces 1-for-20 reverse stock split - Investing.com
iSpecimen announces 1-for-20 reverse stock split By Investing.com - Investing.com Canada
ISpecimen Shares Down Amid Plans for Reverse Stock Split - MarketWatch
iSpecimen Announces Reverse Stock Split for Compliance and Appeal - TipRanks
iSpecimen announces 1-for-20 reverse stock split - Investing.com India
iSpecimen Announces 1-for-20 Reverse Stock Split - StockTitan
iSpecimen (NASDAQ:ISPC) Stock Quotes, Forecast and News Summary - Benzinga
The time has not yet come to remove your chips from the table: iSpecimen Inc (ISPC) - SETE News
Financial Health Report: iSpecimen Inc (ISPC)’s Ratios Tell a Tale - The Dwinnex
iSpecimen Inc (ISPC) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News
iSpecimen (NASDAQ:ISPC) Shares Down 4.9% - Defense World
There is no doubt that iSpecimen Inc (ISPC) ticks all the boxes. - SETE News
ISPC’s Stock Market Adventure: -42.05% YTD Growth Amidst Volatility - The InvestChronicle
Analyzing the Impact of Earnings Reports on iSpecimen Inc Inc. (ISPC) Price Performance - The InvestChronicle
Market Recap Check: iSpecimen Inc (ISPC)’s Negative Finish at 0.29, Up/Down -7.15 - The Dwinnex
It is Poised to be a Bull Market for iSpecimen Inc (ISPC) - SETE News
ISPC’s Q2 earnings estimates: What investors need to know - US Post News
iSpecimen Inc (ISPC) Stock: Navigating a Year of Stock Volatility - The InvestChronicle
iSpecimen Inc (ISPC) is a good investment, but the stock may be undervalued - US Post News
Ispecimen Inc Stock (ISPC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.62%
1.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):